Vectura Share Discussion Threads

[montyhedge] 13/8/2021 07:59

I'm hoping Hikma Pharmaceuticals will be the next one in play.

[base7] 13/8/2021 07:57

My experience too city farmer & started selling down my remaining stake at 173 & yesterday at just over 163,having targeted companies to reinvest in & deciding its not worth waiting months for an additional 1.6p,on the assumption that a further bid does not emerge ( & if it does it us unlikely to exceed 175p max).SKP was an exciting ride & I only generated a decent profit there due to substantial averaging down after the fall from grace.In the end Vec has not been a bad investment as I added substantially at 70-80p although pretty pedestrian until recent bid action.
Thanks too to Polaris & others for their very measured & informed & pragmatic opinions

[montyhedge] 13/8/2021 07:55

It's all over done and dusted.

[demicauk] 13/8/2021 02:14

I personally don't think we have seen the end of the action on this one yet......

[dp1umb] 12/8/2021 21:26

I will hold for now on unless there’s a general market setback.
Unfortunately the shares I had an eye on have all increased markedly in the last week or so.
These being Senior , Aviva , and Glaxo
a bit boring I know but Iam the wrong side of 50. I have mainly been invested in pharma /biotech for the last 20 years. Looking back I got lucky as as the the products that tempted me to invest in these companies either failed or disappointed.
But by chance other therapy’s or mergers saved the day .

[cityfarmer] 12/8/2021 20:55

I must say this BB has been excellent over the years particularly Polaris in recent years. So thanks everyone and I will genuinely miss this BB. I do think its all over now and like many here will be looking for a new home for my dosh. SKP was my biggest holding (by far) so ended up very overweight in VEC. I am pretty sure SKP early days were responsible for my hair loss (am not joking either..) as we did have some very dark days and at one point thought we were toast. Anyway onward and forward perhaps we should all just tip one share for the future? anyway for info my tip (and I hold quite a few) is BXP.

Good luck everyone and good health and fortune
The SKP Daddy

[davr0s] 12/8/2021 20:39

I'm seeing lots of opportunities in recent weeks as I buy strength not weakness. Nearly fully loaded in the PF but won't let go here until all is done

[boadicea] 12/8/2021 20:35

dp1umb - Where to reinvest is the question that causes me to be in no rush to cash in.
I am looking at 4 particular 'cheap' situations. One is a recovery where the news seems to be slowly improving, two are companies that have previously disappointed or upset holders and have a number of impatient ones who presumably sell (misguidedly, I hope) whenever the share price shows signs of rising. The fourth is a rapidly expanding outfit with limited liquidity, a low rating and currently little popular following - potentially the best of the bunch imo.
I am steering clear of covid recovery situations as they're not generally the type of shares I invest in (travel co's, airlines etc) and fortunatley I held virtually none of these.

My holding in VEC was substantial (in my limited terms) so the proceeds will need to be spread about somewhat.

The common factor to each of the 4 candidates is risk of course, but I see it as no more of a risk than holding a strong performing high-flier on a fancy rating which has a hiccup and falls from grace.
The one I am happy to identify at this stage is the recovery one, CPI, as it is highly liquid and unlikely to be influenced by anything written here.

[dp1umb] 12/8/2021 19:12

A1ord I was tempted at 173p . Above 135p is all a bonus really so not that disappointed.Luckily I was purchasing vectura shares at around 80 or even the low 70s.
The hard bit in the next month or two is finding companies to invest in .

[pooroldboy55] 12/8/2021 18:45

Hi GBCol
Very much the same with me here via SKP so reasonably happy. Was beginning to think I would be pushing up daisies before this was sorted.
Cheers to all in the future
POB (ANDREW)

[gbcol] 12/8/2021 18:24

180p+ was the exit figure I always had as a minimum, which is what it was at the time of the SKP/VEC merger. Obviously that was the ideal time for me to get out and save myself a number of frustrating years here.

I suppose if you count the 19p divi then we just about get there but think we have fallen short of “fair value” by about 20p or so.

Nevertheless, this is a multi-bagger for me as I went in big when SKP were on the ropes and not even sure to survive, so overall it’s been well worth the ride. A fitting end though (if this is the end), never quite lived up to hopes and expectations, with a disappointment never far around the corner.

[davr0s] 12/8/2021 17:56

Yeah but that's hindsight bias. Maybe game over maybe not. Always try to not overlay my prejudice on the price action (otherwise I'd go mad with my PF!)

[a1ord53] 12/8/2021 17:16

I think Take over panel interruption was not good decision !

D1 , you was right tempting to sell at 173 p .

Vectura Never was easy stock to hold with a lot of unpleasant surprises !
It finishing with some frustration for holders , although after so much suffer in last years 165p + 19p not bad !

[davr0s] 12/8/2021 17:16

Don't think the RNS changes that much tbh

[davr0s] 12/8/2021 17:15

So we sit and wait.... again

[dp1umb] 12/8/2021 17:08

So that’s it unless another party is interested 165p the agreed price.

[polaris] 12/8/2021 10:37

@slim9 - Not a general pharma expert. VEC knowledge was built up over more than a decade (along with SKP). All i can suggest is reading all their reports from 2016 onwards to see how development schedule met reality and how their future plans are proceeding.

[slim9] 11/8/2021 20:01

hxxps://www.amrytpharma.com/investors/



Polaris .. Any thoughts ?????

Cash rich - money making pharma.

Cheers in advance.

S

[boadicea] 11/8/2021 10:23

I agree, but I don't think the Carlyle offer 'fails' until it is withdrawn or the PMI offer becomes unconditional.

[18bt] 11/8/2021 09:19

boadicea, I would expect that one term of the irrevocables is that they are invalidated if the Carlyle offer fails. At that point they would be able to accept the PMI offer. Hence the importance of PMI turning it from a Scheme to a conventional offer. I don't think Carlyle will change their's to an Offer as there is a chance of them not getting to 90% and therefore being left with a minority and therefore not being able to control the cashflows and then debt structure.

[jimboyce] 11/8/2021 08:21

Time for Hikma to make their move now they know the base cost involved.

[davr0s] 11/8/2021 08:01

What % were pledged to Carlyle ?

[boadicea] 11/8/2021 07:54

Shares that were pledged irrevocably to Carlyle at 155p (~11.2%) presumably remain so pledged unless the PMI offer is raised to at least 170.5p OR becomes unconditional ... or something/someone else emerges.
PMI could go unconditional at 50% but may well not do so as they will need 90% to become compulsory, which is their intention.
My expectation is a PMI raise to 171p in due course.